Geode Capital Management
NVCT icon

Geode Capital Management’s Nuvectis Pharma NVCT Stock Holding History

Geode Capital Management’s Portfolio NVCT Stock Details NVCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.97M Buy
384,105
+20,081
+6% +$172K ﹤0.01% 2975
2025
Q4 		$2.75M Buy
364,024
+38,291
+12% +$250K ﹤0.01% 3052
2025
Q3 		$1.96M Buy
325,733
+40,401
+14% +$278K ﹤0.01% 3186
2025
Q2 		$2.13M Buy
285,332
+149,999
+111% +$1.36M ﹤0.01% 3117
2025
Q1 		$1.32M Buy
135,333
+56,090
+71% +$404K ﹤0.01% 3204
2024
Q4 		$429K Sell
79,243
-473
-0.6% -$2.96K ﹤0.01% 3652
2024
Q3 		$501K Buy
79,716
+26,489
+50% +$174K ﹤0.01% 3580
2024
Q2 		$337K Sell
53,227
-81,301
-60% -$553K ﹤0.01% 3724
2024
Q1 		$1.1M Buy
134,528
+2,871
+2% +$24.4K ﹤0.01% 3330
2023
Q4 		$1.1M Buy
131,657
+1,994
+2% +$17.8K ﹤0.01% 3324
2023
Q3 		$1.67M Buy
129,663
+17,127
+15% +$248K ﹤0.01% 3130
2023
Q2 		$1.8M Buy
112,536
+77,514
+221% +$1.24M ﹤0.01% 3147
2023
Q1 		$459K Buy
35,022
+3,654
+12% +$37K ﹤0.01% 3674
2022
Q4 		$235K Sell
31,368
-73
-0.2% -$523 ﹤0.01% 4008
2022
Q3 		$222K Buy
31,441
+7,474
+31% +$69.6K ﹤0.01% 4145
2022
Q2 		$268K Buy
23,967
+9,145
+62% +$113K ﹤0.01% 4090
2022
Q1 		$109K Buy
+14,822
New +$103K ﹤0.01% 4629

Other funds holding NVCT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
IAM
Iridian Asset Management Westport, Connecticut $247M AUM 20.65% 1-Year Est. Return
OCM
Occam Crest Management Darien, Connecticut $165M AUM
BWP
Baldwin Wealth Partners Marion, Massachusetts $1.53B AUM 28.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management's NVCT Position: Q1 2026 in Review

Geode Capital Management increased its Nuvectis Pharma (NVCT) stake by 5.5% in Q1 2026, buying an estimated $172K and bringing the position to 384,105 shares worth $2.97M. The position accounts for ﹤0.01% of the portfolio, ranked #2975.

Geode Capital Management first reported a position in NVCT in Q1 2022 and has held it in 17 quarters since. 62 funds tracked by Wall St. Rank hold NVCT as of Q1 2026.

  • Geode Capital Management held 384,105 shares of Nuvectis Pharma worth $2.97M as of Q1 2026.
  • Geode Capital Management bought 20,081 Nuvectis Pharma shares in Q1 2026, an estimated $172K.
  • Nuvectis Pharma made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #2975 holding.
  • Geode Capital Management first reported a position in Nuvectis Pharma in Q1 2022 and has held it in 17 quarters since.
  • 62 funds tracked by Wall St. Rank held Nuvectis Pharma as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.